Yang S H, Hong C Y, Yu C L
Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Int Immunopharmacol. 2001 Jun;1(6):1173-82. doi: 10.1016/s1567-5769(01)00051-0.
A new mixed formula of Chinese herbs containing Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9 + 3 + 3 g/day was prescribed for the treatment of patients with perennial allergic rhinitis for 3 months (the composition of each herb is shown in the tables of the article). We classified the patients into high (H-IgE) and low IgE (L-IgE) groups according to the titer of serum total IgE (> 200 KIU/l in H-IgE vs. < 200 KIU/l in L-IgE) and the presence of house dust mite-specific IgE. The nasal symptomatic score in the high IgE group was significantly improved from 7.19 +/- 0.18 before treatment to 2.67 +/- 0.37 after treatment. In addition, the serum total and house dust mite-specific IgE level were also decreased after treatment. For elucidating the working mechanism of the mixed formula, the Th1 (IFN-gamma) and Th2 (IL-4, IL-5, IL-10 and IL-13) cytokine production by phytohemagglutinin (PHA)-stimulated mononuclear cells (2 x 10(6) cells/ml) and cyclooxygenase type 2 (COX-2) mRNA expression in LPS or IL-13-stimulated PMN were compared before and after 3 months of treatment. We found that the mixed formula treatment significantly enhanced IL-10 but decreased IFN-gamma and IL-5 production by PHA-stimulated mononuclear cells. The IL-5 production was also decreased by PHA-stimulated lymphocyte. In addition, the COX-2 mRNA expression in stimulated PMN was significantly suppressed after treatment. These results suggest that the new mixed formula treatment is beneficial to the patients with perennial allergic rhinitis via modulating the function of lymphocytes and neutrophils.
一种新的中药复方配方,由新加香薷饮+小青龙汤+香砂六君子汤按每日9 + 3 + 3克的重量组成,用于治疗常年性变应性鼻炎患者3个月(每种草药的成分见文章表格)。我们根据血清总IgE滴度(高IgE组>200 KIU/l,低IgE组<200 KIU/l)和屋尘螨特异性IgE的存在情况,将患者分为高IgE(H-IgE)和低IgE(L-IgE)组。高IgE组的鼻症状评分从治疗前的7.19±0.18显著改善至治疗后的2.67±0.37。此外,治疗后血清总IgE和屋尘螨特异性IgE水平也降低。为阐明该复方配方的作用机制,比较了治疗3个月前后植物血凝素(PHA)刺激的单核细胞(2×10⁶细胞/ml)产生的Th1(IFN-γ)和Th2(IL-4、IL-5、IL-10和IL-13)细胞因子以及LPS或IL-13刺激的PMN中环氧合酶2(COX-2)mRNA的表达。我们发现,该复方配方治疗显著增强了PHA刺激的单核细胞产生的IL-10,但降低了IFN-γ和IL-5的产生。PHA刺激的淋巴细胞也降低了IL-5的产生。此外,治疗后刺激的PMN中COX-2 mRNA的表达明显受到抑制。这些结果表明,这种新的复方配方治疗通过调节淋巴细胞和中性粒细胞的功能,对常年性变应性鼻炎患者有益。